The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 29, 2015
Filed:
Apr. 18, 2011
Heiko Kroth, Ecublens, CH;
Cotinica Hamel, Bussigny-pres-Lausanne, CH;
Pascal Benderitter, Orbe, CH;
Wolfgang Froestl, Ecublens, CH;
Nampally Sreenivasachary, Ecublens, CH;
Andreas Muhs, Pully/VD, CH;
Heiko Kroth, Ecublens, CH;
Cotinica Hamel, Bussigny-pres-Lausanne, CH;
Pascal Benderitter, Orbe, CH;
Wolfgang Froestl, Ecublens, CH;
Nampally Sreenivasachary, Ecublens, CH;
Andreas Muhs, Pully/VD, CH;
AC Immune SA, Lausanne, CH;
Abstract
The present invention relates to novel compounds that can be employed in the treatment of a group of disorders and abnormalities associated with amyloid protein, such as Alzheimer's disease, and of diseases or conditions associated with amyloid-like proteins. The compounds of the present invention can also be used in the treatment of ocular diseases associated with pathological abnormalities/changes in the tissues of the visual system. The present invention further relates to pharmaceutical compositions comprising these compounds and to the use of these compounds for the preparation of medicaments for treating or preventing diseases or conditions associated with amyloid and/or amyloid-like proteins. A method of treating or preventing diseases or conditions associated with amyloid and/or amyloid-like proteins is also disclosed.